{
    "Trade/Device Name(s)": [
        "Dimension Vista CTNI Flex reagent cartridge"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K063756",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010313"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "March 19, 2007",
    "Summary Letter Received Date": "December 19, 2006",
    "Submission Date": "December 18, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac troponin I"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "LOCITM technology"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista CTNI Flex reagent cartridge, a chemiluminescent immunoassay for cardiac troponin I on the Dimension Vista System.",
    "Indications for Use Summary": "For quantitative measurement of cardiac troponin I in human serum and plasma on the Dimension Vista System to aid diagnosis of acute myocardial infarction and risk stratification of acute coronary syndrome patients.",
    "fda_folder": "Clinical Chemistry"
}